EyeGene Inc Working Capital to Net Assets Ratio
EyeGene Inc working capital to net assets ratio. EyeGene Inc (185490) has a Working Capital to Net Assets ratio of 66.6% as of March 2026. Working capital of ₩33.94 Billion (current assets of ₩43.99 Billion minus current liabilities of ₩10.06 Billion) is measured against net assets of ₩50.92 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check EyeGene Inc (185490) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of EyeGene Inc (2014–2025)
Working capital to net assets ratio of EyeGene Inc from 2014 to 2025. This chart shows how EyeGene Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 66.6%, reflecting working capital of ₩33.94 Billion against net assets of ₩50.92 Billion KRW. See EyeGene Inc (185490) liquidity interval to measure how many days the company can operate on defensive assets alone.
EyeGene Inc Working Capital to Net Assets Ratio by Year (2014–2025)
EyeGene Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for EyeGene Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 185490 asset base.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 69.4% | ₩37.63 Billion | ₩54.25 Billion | ₩47.64 Billion | ₩10.00 Billion | ▲ +21.1 pp |
| 2024 | 48.3% | ₩24.30 Billion | ₩50.32 Billion | ₩35.30 Billion | ₩11.00 Billion | ▼ -30.6 pp |
| 2023 | 78.9% | ₩50.78 Billion | ₩64.33 Billion | ₩56.88 Billion | ₩6.10 Billion | ▼ -16.8 pp |
| 2022 | 95.8% | ₩63.91 Billion | ₩66.73 Billion | ₩68.83 Billion | ₩4.92 Billion | ▲ +6.9 pp |
| 2021 | 88.8% | ₩79.03 Billion | ₩88.97 Billion | ₩88.64 Billion | ₩9.61 Billion | ▼ -125.4 pp |
| 2020 | 214.2% | ₩27.63 Billion | ₩12.90 Billion | ₩36.12 Billion | ₩8.49 Billion | ▲ +79.1 pp |
| 2019 | 135.0% | ₩25.70 Billion | ₩19.03 Billion | ₩43.15 Billion | ₩17.45 Billion | ▼ -74.2 pp |
| 2018 | 209.2% | ₩48.84 Billion | ₩23.34 Billion | ₩50.43 Billion | ₩1.59 Billion | ▲ +110.0 pp |
| 2017 | 99.3% | ₩23.58 Billion | ₩23.75 Billion | ₩24.83 Billion | ₩1.25 Billion | ▲ +24.8 pp |
| 2016 | 74.4% | ₩12.05 Billion | ₩16.19 Billion | ₩13.21 Billion | ₩1.16 Billion | ▼ -24.2 pp |
| 2015 | 98.6% | ₩22.44 Billion | ₩22.76 Billion | ₩23.52 Billion | ₩1.08 Billion | ▲ +2.5 pp |
| 2014 | 96.1% | ₩3.70 Billion | ₩3.85 Billion | ₩4.70 Billion | ₩994.56 Million | — |